162 related articles for article (PubMed ID: 34439083)
41. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
42. Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia.
Mat Yusoff Y; Abu Seman Z; Othman N; Kamaluddin NR; Esa E; Zulkiply NA; Abdullah J; Zakaria Z
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1749-1755. PubMed ID: 31244296
[TBL] [Abstract][Full Text] [Related]
43. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia.
Lit BM; Kwong YL; Wong KF
J Clin Pathol; 2016 May; 69(5):409-14. PubMed ID: 26500335
[TBL] [Abstract][Full Text] [Related]
45. Fms like tyrosine kinase (FLT3) and nucleophosmin 1 (NPM1) mutations in de novo normal karyotype acute myeloid leukemia (AML).
Dunna NR; Rajappa S; Digumarti R; Vure S; Kagita S; Damineni S; Rao VR; Yadav SK; Ravuri RR; Satti V
Asian Pac J Cancer Prev; 2010; 11(6):1811-6. PubMed ID: 21338238
[TBL] [Abstract][Full Text] [Related]
46. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia with FLT3-ITD Mutation].
Liu Y; Ke XY; Wang J; Wang JJ; Jing HM; Dong F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):354-358. PubMed ID: 29665898
[TBL] [Abstract][Full Text] [Related]
47. NPM1, FLT3-ITD, CEBPA, and c-kit mutations in 312 Chinese patients with de novo acute myeloid leukemia.
Su L; Gao SJ; Li W; Tan YH; Cui JW; Hu RP
Hematology; 2014 Sep; 19(6):324-8. PubMed ID: 24164801
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world].
Jia JS; Zhu HH; Gong LZ; Zhao T; Wang J; Jiang Q; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):398-403. PubMed ID: 31207705
[No Abstract] [Full Text] [Related]
49. Acute Myeloid Leukaemia with Gene Mutation: A Correlation with Haematological and Immunophenotypic Characteristics and Our Experience in a Tertiary Care Cancer Center in South India.
Khera R; Ahmed F; Mundada M; Nambaru L; Murthy SS; Devig S; Rajappa SJ; Mallavarapu KM; Santa A; Kumar P
Turk Patoloji Derg; 2018; 34(2):171-174. PubMed ID: 28984348
[TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.
Schnittger S; Bacher U; Kern W; Alpermann T; Haferlach C; Haferlach T
Leukemia; 2011 Aug; 25(8):1297-304. PubMed ID: 21537333
[TBL] [Abstract][Full Text] [Related]
51. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).
Falini B; Macijewski K; Weiss T; Bacher U; Schnittger S; Kern W; Kohlmann A; Klein HU; Vignetti M; Piciocchi A; Fazi P; Martelli MP; Vitale A; Pileri S; Miesner M; Santucci A; Haferlach C; Mandelli F; Haferlach T
Blood; 2010 May; 115(18):3776-86. PubMed ID: 20203266
[TBL] [Abstract][Full Text] [Related]
52. FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.
Sorcini D; Stella A; Scialdone A; Sartori S; Marra A; Rossi R; De Falco F; Adamo FM; Dorillo E; Geraci C; Arcaleni R; Rompietti C; Esposito A; Moretti L; Mameli MG; Martelli MP; Falini B; Sportoletti P
EJHaem; 2023 Nov; 4(4):1100-1104. PubMed ID: 38024637
[TBL] [Abstract][Full Text] [Related]
53. FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand.
Mevatee P; Tantiworawit A; Traisathit P; Puaninta C; Mevatee U; Angsuchawan S; Bumroongkit K
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3031-3039. PubMed ID: 29172276
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
[TBL] [Abstract][Full Text] [Related]
55. Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia.
De Bellis E; Ottone T; Mercante L; Falconi G; Cugini E; Consalvo MI; Travaglini S; Paterno G; Piciocchi A; Rossi ELL; Gurnari C; Maurillo L; Buccisano F; Arcese W; Voso MT
Leuk Res; 2020 Dec; 99():106462. PubMed ID: 33091616
[TBL] [Abstract][Full Text] [Related]
56. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.
Dalal BI; Mansoor S; Manna M; Pi S; Sauro GD; Hogge DE
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):274-9. PubMed ID: 22481022
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).
Thiede C; Koch S; Creutzig E; Steudel C; Illmer T; Schaich M; Ehninger G
Blood; 2006 May; 107(10):4011-20. PubMed ID: 16455956
[TBL] [Abstract][Full Text] [Related]
58. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
Mori Y; Yoshimoto G; Kumano T; Miyamoto T; Iino T; Takenaka K; Iwasaki H; Harada N; Kinukawa N; Nagafuji K; Teshima T; Shimoda K; Akashi K; Harada M
Eur J Haematol; 2007 Jul; 79(1):17-24. PubMed ID: 17598835
[TBL] [Abstract][Full Text] [Related]
59. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
Kansal R
Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
[TBL] [Abstract][Full Text] [Related]
60. Description of lymphocyte and cytokine profiles in individuals with acute myeloid leukemia associated with FLT3-ITD and NPM1 mutation status.
Reis R; Müller GS; Santos MM; Santos AS; Santos H; Santos LS; Lopes BA; Trindade SC; Meyer RJ; Freire SM
Eur J Cancer Prev; 2024 Jun; ():. PubMed ID: 38904445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
